Table 2. Allogeneic stem cell transplantation for myelofibrosis.
Author | N | Median age (years) | 1-year TRM, % | 5-year overall survival, % | 5-year progression free-survival, % |
---|---|---|---|---|---|
Ballen et al.15 | 289 | 47 | 27 (sibling), 43 (unrelated) | 37 (sibling), 30 (unrelated) | 33 (sibling), 27 (unrelated) |
Patriarca et al.16 | 100 | 49 | 35 | 31 | 28 |
Robin et al.17 | 147 | 53 | 29 (4 years) | 39 (4 years) | 32 (4 years) |
Kerbauy et al.22 | 104 | 47 | 27 | 61 (7 years) | — |
Deeg et al.21 | 56 | 43 | 35 | 58 | — |
Abbreviation: TRM, transplant-related mortality.